secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001104659-22-120162
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Armata shareholders elect seven directors, approve executive compensation, ratify EY auditor
--------------------------------------------------------------------------------

- All seven director nominees elected with between 30.2M and 31.0M votes for each; broker non-votes 858,850.
- Non-binding advisory vote on 2021 executive compensation passed: 31,049,313 for, 28,667 against, 14,615 abstain.
- Ratification of Ernst & Young as independent auditor for FY2022 passed: 31,938,703 for, 6,798 against, 5,944 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465922120162/0001104659-22-120162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465922120162/tm2230880d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-120162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer